072020.KS · 중앙백신
South Korea · RS rating 50 · As of 2026-10-14
| Price | 9,010.00 KRW |
|---|---|
| 1-day change | -0.2% |
| RS rating (overall / 1M / 3M / 12M) | 50 / 49 / 31 / 56 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 34 / 49 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | -58.2% |
| Sales growth Q/Q | -5.5% |
| Distance from 52-week high | +11.1% |
| Market cap (USD) | $63.2M |